Management of a Type I Hypersensitivity Reaction to IV Etoposide in a Woman with a Yolk Sac Tumor: A Case Report

• Egile Nagusiak: David Starks (Egilea), Deborah Prinz (Egilea), Amy Armstrong (Egilea), Lindsay Means (Egilea), Steven Waggoner (Egilea), Robert DeBernardo (Egilea)
• Formatua: Liburua
• Argitaratua: Hindawi Limited, 2011-01-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Type I hypersensitivity reactions to intravenous administration of etoposide are extremely rare. Etoposide is an essential component of several chemotherapy regimens used in gynecologic oncology, and discontinuation of this drug during a course of treatment should only be due to severe patient intol...